UGC Approved Journal no 63975(19)
New UGC Peer-Reviewed Rules

ISSN: 2349-5162 | ESTD Year : 2014
Volume 12 | Issue 10 | October 2025

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 12 Issue 7
July-2025
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2507412


Registration ID:
566517

Page Number

d964-d1005

Share This Article


Jetir RMS

Title

FORMULATION AND EVALUATION OF GASTRORETENTIVE FLOATING TABLET OF LISINOPRIL

Abstract

The present work involves the design, development and in-vitro evaluation of Lisinopril floating pulsatile release tablet, in which the core tablets are rapid release formulation which is coated with hydrophilic polymers such as HPMC E15, HPMC K15M, HPMC K4M, Xanthan gum individually and in combination. FPRT was designed for the treatment of morning surge of Hypertension The rapid release core tablets of Lisinopril were formulated with various concentrations of SSG (2%, 3% and 4%), CCS (1%, 1.5% and 2%) and Crospovidone (2 %, 3.5% and 5%) by direct compression. The in-vitro dissolution studies of the formulated Lisinopril Core tablets were performed using USP type-II dissolution apparatus. From the formulated batches, the formulation F3 released the drug very quickly (within 4 minutes) when compared to other formulations. Based on the Disintegration and in-vitro release studies of Lisinopril rapid release core tablets, formulation F3 was optimized and selected for Press coating. The formulated Lisinopril FPRTs were found to be within limits with respect to Weight uniformity, Hardness, Thickness, Diameter and Friability. The drug content of the Lisinopril FPRTs were estimated and found to be within Pharmacopoeial limits. The formulated Lisinopril FPRTs were found to be within limits with respect to Weight uniformity, Hardness, Thickness, Diameter and Friability. The drug content of the Lisinopril FPRTs were estimated and found to be within Pharmacopoeial limits.

Key Words

Keywords: gastroretentive, lisinopril, floating tablets.

Cite This Article

"FORMULATION AND EVALUATION OF GASTRORETENTIVE FLOATING TABLET OF LISINOPRIL", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.12, Issue 7, page no.d964-d1005, July-2025, Available :http://www.jetir.org/papers/JETIR2507412.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"FORMULATION AND EVALUATION OF GASTRORETENTIVE FLOATING TABLET OF LISINOPRIL", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.12, Issue 7, page no. ppd964-d1005, July-2025, Available at : http://www.jetir.org/papers/JETIR2507412.pdf

Publication Details

Published Paper ID: JETIR2507412
Registration ID: 566517
Published In: Volume 12 | Issue 7 | Year July-2025
DOI (Digital Object Identifier): https://doi.org/10.56975/jetir.v12i7.566517
Page No: d964-d1005
Country: Karimnagar, Telangana, India .
Area: Pharmacy
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

00091

Print This Page

Current Call For Paper

Jetir RMS